Search Results - "Cree, B. A. C."

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring by Block, V. J., Lizée, A., Crabtree-Hartman, E., Bevan, C. J., Graves, J. S., Bove, R., Green, A. J., Nourbakhsh, B., Tremblay, M., Gourraud, P.-A., Ng, M. Y., Pletcher, M. J., Olgin, J. E., Marcus, G. M., Allen, D. D., Cree, B. A. C., Gelfand, J. M.

“…Disability measures in multiple sclerosis (MS) rely heavily on ambulatory function, and current metrics fail to capture potentially important variability in…”
Get full text

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome by OKUDA, D. T, MOWRY, E. M, CREE, B. A. C, CRABTREE, E. C, GOODIN, D. S, WAUBANT, E, PELLETIER, D

“…Technological advancements in neuroimaging and the increased use of these diagnostic modalities are responsible for the discovery of incidentally identified…”
Get full text

Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis by Green, A J, Cree, B A C

“…Patients and methods:This is a cross sectional study comparing the retinal features of optic neuritis (ON) between 20 multiple sclerosis (MS) and 16…”
Get full text

Vitamin D in African Americans with multiple sclerosis by GELFAND, J. M, CREE, B. A. C, MCELROY, J, OKSENBERG, J, GREEN, R, MOWRY, E. M, MILLER, J. W, HAUSER, S. L, GREEN, A. J

“…To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans. Serum 25-hydroxyvitamin D was…”
Get full text

Multiple sclerosis susceptibility alleles in African Americans by Johnson, B A, Wang, J, Taylor, E M, Caillier, S J, Herbert, J, Khan, O A, Cross, A H, De Jager, P L, Gourraud, P-A F, Cree, B C A, Hauser, S L, Oksenberg, J R

“…Multiple sclerosis (MS) is an autoimmune demyelinating disease characterized by complex genetics and multifaceted gene–environment interactions. Compared to…”
Get full text

Genotype–Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures by Okuda, D. T., Srinivasan, R., Oksenberg, J. R., Goodin, D. S., Baranzini, S. E., Beheshtian, A., Waubant, E., Zamvil, S. S., Leppert, D., Qualley, P., Lincoln, R., Gomez, R., Caillier, S., George, M., Wang, J., Nelson, S. J., Cree, B. A. C., Hauser, S. L., Pelletier, D.

“…Genetic susceptibility to multiple sclerosis (MS) is associated with the human leukocyte antigen (HLA) DRB1*1501 allele. Here we show a clear association…”
Get full text

An open label study of the effects of rituximab in neuromyelitis optica by CREE, B. A. C, LAMB, S, MORGAN, K, CHEN, A, WAUBANT, E, GENAIN, C

“…Eight patients with worsening neuromyelitis optica were treated with rituximab to achieve B cell depletion. Treatment was well tolerated. Six of eight patients…”
Get full text

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis by CREE, B. A. C, KHAN, O, HAINES, J. L, PERICAK-VANCE, M, DELOA, C, OKSENBERG, J. R, HAUSER, S. L, BOURDETTE, D, GOODIN, D. S, COHEN, J. A, MARRIE, R. A, GLIDDEN, D, WEINSTOCK-GUTTMAN, B, REICH, D, PATTERSON, N

“…African American (AA) individuals are thought to develop multiple sclerosis (MS) less frequently than Caucasian American (CA) individuals. To compare the…”
Get full text

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions by Frohman, E M, Filippi, M, Stuve, O, Waxman, S G, Corboy, J, Phillips, J T, Lucchinetti, C, Wilken, J, Karandikar, N, Hemmer, B, Monson, N, De Keyser, J, Hartung, H, Steinman, L, Oksenberg, J R, Cree, B A C, Hauser, S, Racke, M K

“…Major advancements have been achieved in our ability to diagnose multiple sclerosis (MS) and to commence treatment intervention with agents that can favorably…”
Get more information

Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans by Brassat, D, Motsinger, A A, Caillier, S J, Erlich, H A, Walker, K, Steiner, L L, Cree, B A C, Barcellos, L F, Pericak-Vance, M A, Schmidt, S, Gregory, S, Hauser, S L, Haines, J L, Oksenberg, J R, Ritchie, M D

“…Multiple sclerosis (MS) is a common disease of the central nervous system characterized by inflammation, myelin loss, gliosis, varying degrees of axonal…”
Get full text

P516 Humoral immune responses to SARS-CoV-2 vaccines in an ozanimod open-label extension study by Caldera, F, Maddux, R, Ungaro, R, Kaur, A, Brown, E, Hu, S, Sheffield, J K, Silva, D, Harris, S, Cree, B A C

“…Abstract Background Ozanimod, an oral sphingosine 1-phosphate receptor modulator, is approved in the European Union and United States for the treatment of…”
Get full text

P402 Incidence and outcomes of herpes zoster in the ozanimod phase, 3 ulcerative colitis and relapsing multiple sclerosis clinical program by Siegmund, B, Melmed, G Y, Irving, P M, Pai, A, Patel, A, Sheffield, J K, Caldera, F, Cree, B A C, Dubinsky, M C

“…Abstract Background Patients with ulcerative colitis (UC) and patients with multiple sclerosis (MS) have an elevated risk of developing herpes zoster (HZ),…”
Get full text

P486 Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trials by Ungaro, R, Siegel, C A, Cree, B A C, Selmaj, K W, Ahmad, H A, Pai, A, Ather, S, Henry, A, Charles, L, Petersen, A, Cheng, C Y, Afsari, S, Sheffield, J, Vaile, J, Colombel, J F

“…Abstract Background Ozanimod, a sphingosine 1-phosphate (S1P) receptor S1P1 and S1P5 modulator, is approved in the United States for moderately to severely…”
Get full text

Genotype-Phenotype Correlations in Multiple Sclerosis: "HLA" Genes Influence Disease Severity Inferred by [superscript 1]HMR Spectroscopy and MRI Measures by Okuda, D. T, Srinivasan, R, Oksenberg, J. R, Goodin, D. S, Baranzini, S. E, Beheshtian, A, Waubant, E, Zamvil, S. S, Leppert, D, Qualley, P, Lincoln, R, Gomez, R, Caillier, S, George, M, Wang, J, Nelson, S. J, Cree, B. A. C, Hauser, S. L, Pelletier, D

“…Genetic susceptibility to multiple sclerosis (MS) is associated with the human leukocyte antigen (HLA) "DRB1*1501" allele. Here we show a clear association…”
Get full text

Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis by Caillier, S. J., Briggs, F., Cree, B. A. C., Baranzini, S. E., Fernandez-Viña, M., Ramsay, P. P., Khan, O., Royal, W., Hauser, S. L., Barcellos, L. F., Oksenberg, J. R.

Get full text